Vancouver, British Columbia--(Newsfile Corp. - November 14, 2018) - Knol Resources Corp. (TSXV: NOL.H) (the "Corporation") and Pivot Pharmaceuticals Inc. announce that they have mutually agreed to terminate their previously announced Letter of Intent dated October 3, 2018.

Accordingly, it is anticipated that the common shares of Knol will resume trading at the open of the market on Friday, November 16, 2018.

For further information, please contact:

Michael Atkinson, President and Chief Executive Officer of Knol Resources Corp.
Email: atkinson@earlston.ca
Phone: (604) 689-1428

Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Source: Reklaim